CN102220345B - 重组犬α干扰素的优化基因、菌种及高效表达 - Google Patents
重组犬α干扰素的优化基因、菌种及高效表达 Download PDFInfo
- Publication number
- CN102220345B CN102220345B CN 201110139692 CN201110139692A CN102220345B CN 102220345 B CN102220345 B CN 102220345B CN 201110139692 CN201110139692 CN 201110139692 CN 201110139692 A CN201110139692 A CN 201110139692A CN 102220345 B CN102220345 B CN 102220345B
- Authority
- CN
- China
- Prior art keywords
- interferon
- recombinant
- expression
- interferon alpha
- alpha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000282465 Canis Species 0.000 title claims abstract description 23
- 230000014509 gene expression Effects 0.000 title abstract description 29
- 108090000623 proteins and genes Proteins 0.000 title abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 15
- 241000588724 Escherichia coli Species 0.000 claims abstract description 12
- 108010047761 Interferon-alpha Proteins 0.000 claims description 37
- 102000006992 Interferon-alpha Human genes 0.000 claims description 29
- 238000004153 renaturation Methods 0.000 claims description 10
- 229920002684 Sepharose Polymers 0.000 claims description 4
- 238000005215 recombination Methods 0.000 claims description 4
- 230000006798 recombination Effects 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 3
- 238000000855 fermentation Methods 0.000 claims description 2
- 230000004151 fermentation Effects 0.000 claims description 2
- 238000005342 ion exchange Methods 0.000 claims description 2
- 238000004255 ion exchange chromatography Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims 1
- 238000013467 fragmentation Methods 0.000 claims 1
- 238000006062 fragmentation reaction Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 17
- 239000013604 expression vector Substances 0.000 abstract description 8
- 102000004169 proteins and genes Human genes 0.000 abstract description 8
- 241000894006 Bacteria Species 0.000 description 21
- 210000003000 inclusion body Anatomy 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 8
- 102000014150 Interferons Human genes 0.000 description 8
- 108010050904 Interferons Proteins 0.000 description 8
- 229940079322 interferon Drugs 0.000 description 8
- 125000003396 thiol group Chemical group [H]S* 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 230000009182 swimming Effects 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 230000000968 intestinal effect Effects 0.000 description 6
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 241000700605 Viruses Species 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000005457 optimization Methods 0.000 description 5
- 108020004705 Codon Proteins 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 238000003259 recombinant expression Methods 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 210000001072 colon Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000005063 solubilization Methods 0.000 description 3
- 230000007928 solubilization Effects 0.000 description 3
- 238000000108 ultra-filtration Methods 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000711975 Vesicular stomatitis virus Species 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000005277 cation exchange chromatography Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 235000003969 glutathione Nutrition 0.000 description 2
- YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 108010066925 sleep-promoting factor B Proteins 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241001655322 Streptomycetales Species 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 241000405217 Viola <butterfly> Species 0.000 description 1
- 150000001370 alpha-amino acid derivatives Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000000498 ball milling Methods 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- 125000002228 disulfide group Chemical group 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 206010048282 zoonosis Diseases 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110139692 CN102220345B (zh) | 2011-05-27 | 2011-05-27 | 重组犬α干扰素的优化基因、菌种及高效表达 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110139692 CN102220345B (zh) | 2011-05-27 | 2011-05-27 | 重组犬α干扰素的优化基因、菌种及高效表达 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102220345A CN102220345A (zh) | 2011-10-19 |
CN102220345B true CN102220345B (zh) | 2013-01-02 |
Family
ID=44777049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110139692 Active CN102220345B (zh) | 2011-05-27 | 2011-05-27 | 重组犬α干扰素的优化基因、菌种及高效表达 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102220345B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106282279A (zh) * | 2016-08-25 | 2017-01-04 | 安徽九川生物科技有限公司 | 一种重组犬干扰素α标准品、其制备方法及效价测定方法 |
CN110904115B (zh) * | 2019-12-25 | 2021-08-17 | 安徽九川生物科技有限公司 | 犬重组干扰素α7及其制备方法与应用、含有犬重组干扰素α7的表达载体及宿主细胞 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100572393C (zh) * | 2006-04-06 | 2009-12-23 | 北京江中泽生科技有限责任公司 | 犬干扰素α制备方法和用途 |
CN101209345B (zh) * | 2006-12-26 | 2012-02-01 | 河南农业大学 | 一种动物基因工程干扰素α和γ复合制剂及其生产方法 |
-
2011
- 2011-05-27 CN CN 201110139692 patent/CN102220345B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102220345A (zh) | 2011-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112552393B (zh) | 一种重组人源iii型胶原蛋白及其毕赤酵母重组表达系统 | |
CN103087200B (zh) | 猪IFNγ-Fc融合蛋白及其编码基因和表达方法 | |
CN105061589A (zh) | 一种重组人ⅰ型胶原蛋白及其固定化发酵生产的方法 | |
CN102146135A (zh) | 一种重组类人胶原蛋白及其生产方法 | |
CN101736062B (zh) | 一种重组猪α干扰素标准品的制备方法 | |
CN102154189A (zh) | 一种rhG-CSF重组工程菌的发酵培养方法 | |
CN103045492A (zh) | 一种汉逊酵母表达系统及其构建方法和应用 | |
WO2023221787A1 (zh) | 重组i型胶原蛋白毕赤酵母工程菌及其构建方法与应用 | |
CN101974587A (zh) | 一种高效表达人血清白蛋白的方法 | |
CN103898153A (zh) | 一种多拷贝的金属硫蛋白重组表达载体及其高效表达金属硫蛋白的方法 | |
CN102220345B (zh) | 重组犬α干扰素的优化基因、菌种及高效表达 | |
CN100357441C (zh) | 重组人神经生长因子的酵母表达系统及制备重组人神经生长因子的方法 | |
CN103319608B (zh) | 猪IFNɑ1-Fc融合蛋白及其编码基因和表达方法 | |
CN101429519A (zh) | 重组人胰岛素样生长因子-1(igf-1)融合蛋白的制备方法 | |
CN102286490B (zh) | 一种鸡干扰素γ的制备复性方法 | |
CN101665798A (zh) | 一种制备重组人血清白蛋白与干扰素α融合蛋白的方法 | |
CN105002103A (zh) | 一种重组g-csf(15-75)多肽毕赤酵母菌的发酵方法 | |
CN103966253A (zh) | 一种高效制备重组人白细胞介素-33蛋白的方法 | |
CN1746306B (zh) | 一种重组人干扰素α4编码cDNA序列及其制备方法和应用 | |
CN103613668B (zh) | 犬、猫长效融合干扰素及其制备方法与应用 | |
CN103589769B (zh) | 一种重组猪干扰素α1基因工程菌的高密度发酵方法 | |
CN102167733A (zh) | 一种可酸切高拷贝降血压肽串联基因的构建、表达及应用 | |
CN102010867A (zh) | 重组中华蜜蜂王浆主蛋白AccMRJP1的酵母表达方法及产物用途 | |
CN103146631A (zh) | 一种表达可溶性猪γ-干扰素PoIFN-γ的基因工程菌及其构建方法和应用 | |
CN103880948A (zh) | 人中性粒细胞明胶酶相关载脂蛋白(ngal)的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Recombinant canine alpha-interferon optimized gene, strain and efficient expression Effective date of registration: 20171130 Granted publication date: 20130102 Pledgee: China Co truction Bank Corp Beijing Zhongguancun branch Pledgor: Sino-Kingbio Biotech Co.,Ltd. Registration number: 2017990001104 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190219 Granted publication date: 20130102 Pledgee: China Co truction Bank Corp Beijing Zhongguancun branch Pledgor: Sino-Kingbio Biotech Co.,Ltd. Registration number: 2017990001104 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Recombinant canine alpha-interferon optimized gene, strain and efficient expression Effective date of registration: 20190304 Granted publication date: 20130102 Pledgee: China Co truction Bank Corp Beijing Zhongguancun branch Pledgor: Sino-Kingbio Biotech Co.,Ltd. Registration number: 2019990000169 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200910 Granted publication date: 20130102 Pledgee: China Co. truction Bank Corp Beijing Zhongguancun branch Pledgor: Sino-Kingbio Biotech Co.,Ltd. Registration number: 2019990000169 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210802 Address after: 301800 No. 1, Baoshan Road, Zhongguancun Science and Technology City, Beijing and Tianjin, Baodi District, Tianjin Patentee after: Zhongkebaike (Tianjin) biopharmaceutical Co.,Ltd. Address before: 100085 floor 2, building 13, No. 2, Nansi street, Zhongguancun, Haidian District, Beijing Patentee before: Sino-Kingbio Biotech Co.,Ltd. |